• August 26 , 2020

    Detecting pancreatic cancer at treatable stages

    Pancreatic cancer is rarely detected at its early stages because symptoms often do not present themselves until after the cancer has progressed. By then, invasive procedures such as surgery, chemotherapy or radiation are often needed to treat the cancer.
    Read more
  • August 25 , 2020

    New blood, new hope: Transfusions protect the brain from stroke damage

    Muscle weakness permeates through one side of your body and your speech slurs. It's a stroke. And you need to be rushed to the emergency room.
    Read more
  • August 24 , 2020

    Splitting immunotoxins in half could increase their specificity toward cancers, study suggests

    Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
    Read more
  • August 23 , 2020

    Using hydroxychloroquine and azithromycin together increases cardiovascular risk

    The combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed comparing hydroxychloroquine treatment to hydroxychloroquine and azithromycin treatment for rheumatoid arthritis patients. Hydroxychloroquine is commonly used to treat rheumatoid arthritis
    Read more
  • August 21 , 2020

    Genomic analysis reveals many animal species may be vulnerable to SARS-CoV-2 infection

    Humans are not the only species facing a potential threat from SARS-CoV-2, the novel coronavirus that causes COVID-19, according to a new study from the University of California, Davis.
    Read more
  • August 20 , 2020

    Surgical innovation promises better dialysis outcomes

    A new technique developed by a Yale-led research team improves blood flow in surgically made blood vessels used in dialysis, enables them to last longer, and results in fewer complications than the standard technique.
    Read more
  • August 19 , 2020

    Study finds cancer-boosting culprit that multiplies with age

    As our bodies convert food into energy, they produce debris that accumulates as we age. New research shows that one of these metabolic throwaways plays a potentially deadly role in the development of cancer.
    Read more
  • August 18 , 2020

    Acidic niche keeps lymphatic system in check during immune response

    In the fight against cancer, the immune system is the first line of defense. The lymphatic system specifically is essential to protecting the body against foreign invaders. Activation of immune cells in the lymph nodes leads to the production and release of antibodies, and activation of lymphocytes, including T cells, to battle infection. But little is known
    Read more
  • August 17 , 2020

    Potency-enhancing drugs linked to decreased risks in men with colorectal cancer

    A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Commu
    Read more
  • August 16 , 2020

    Evidence reviews support avoiding opioid prescriptions for sprains and strains

    Two new evidence reviews related to acute musculoskeletal injuries like strains and sprains suggest other forms of treatments are as effective as opioids and have less risk of harms to patients.
    Read more
  • August 14 , 2020

    Probe detects the destruction of defective mitochondria

    A versatile probe that can detect with pinpoint accuracy the programmed destruction of defective mitochondria—the powerhouses of cells—has been developed by RIKEN researchers. They used it to show that damaged mitochondria in dopamine-producing neurons fail to be destroyed in mice with a condition resembling Parkinson's disease.
    Read more
  • August 13 , 2020

    Experimental treatment confers benefits for the alleviation of nonalcoholic hepatic steatosis

    Prof. Liu Hongwei's group and Prof. Liu Shuangjiang's group from the Institute of Microbiology of the Chinese Academy of Sciences has reported the anti-NAFLD effects of a Ganoderma meroterpene derivative that increased the abundance of Bacteroides spp. to activate Bacteroides-folate-liver pathway and further alleviate nonalcoholic fatty liver disease (NAFLD)
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us